Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.

2025 Year in Review Video Series Part 1_ Psychedelics in 2025

Video

2025 Year in Review: Psychedelics in 2025 (Video)

Watch the first video in our 2025 Year in Review series. This narrated slide deck, presented by Psychedelic Alpha Founder & Editor Josh Hardman, looks back on 2025 and takes stock of where the psychedelics field stands today across drug development, policy, and access programs.

This first presentation covers:

  • Investment in psychedelics companies
  • The drug development pipeline and key trends
  • Lobbying activity and political realities
  • Public perceptions
  • A Dispatch from Washington, D.C.
  • U.S. state-level reforms
  • International developments in Australia, Czechia, Germany, Norway, and Canada.

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200
  • Regular Bulletins featuring news, analysis, and research
  • Articles and deep dives across psychedelic drug development, policy, and research
  • Exclusive interviews with researchers, executives, and policymakers
  • Bespoke resources and tools including the Psychedelic Bill Tracker
  • Quarterly video briefings and slide decks

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200

Subscribe to our
free newsletter


By signing up, you agree to our privacy policy. You can unsubscribe at any time.

Learn More About

Group, team &
corporate plans


Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.